158 related articles for article (PubMed ID: 9554447)
1. Re: Biology of cachexia.
Wheeler BM
J Natl Cancer Inst; 1998 Apr; 90(8):628. PubMed ID: 9554447
[No Abstract] [Full Text] [Related]
2. Continuing: Biology of cachexia.
Bozzetti F
J Natl Cancer Inst; 1999 Jun; 91(12):1077; author reply 1077-8. PubMed ID: 10379972
[No Abstract] [Full Text] [Related]
3. More about: biology of cachexia.
Gold J
J Natl Cancer Inst; 1998 Jul; 90(14):1101-2. PubMed ID: 9672260
[No Abstract] [Full Text] [Related]
4. [Drug therapy of cancer cachexia].
Ovesen LF
Ugeskr Laeger; 1994 Jan; 156(2):203-6. PubMed ID: 8296415
[No Abstract] [Full Text] [Related]
5. Continuing: Biology of cachexia.
Gold J
J Natl Cancer Inst; 1999 Jun; 91(12):1077; author reply 1077-8. PubMed ID: 10379973
[No Abstract] [Full Text] [Related]
6. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
7. Anorexia and cachexia in advanced cancer patients.
Vigano A; Watanabe S; Bruera E
Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
[TBL] [Abstract][Full Text] [Related]
8. Supportive care drug studies: some promising, some not.
Oncology (Williston Park); 1992 Sep; 6(9):93-4. PubMed ID: 1333264
[No Abstract] [Full Text] [Related]
9. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
[No Abstract] [Full Text] [Related]
10. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.
Advani SM; Advani PG; VonVille HM; Jafri SH
BMC Cancer; 2018 Nov; 18(1):1174. PubMed ID: 30482179
[TBL] [Abstract][Full Text] [Related]
11. Hydrazine sulfate ad is "offensive".
Jenks S
J Natl Cancer Inst; 1993 Apr; 85(7):528-9. PubMed ID: 8455198
[No Abstract] [Full Text] [Related]
12. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
Currow DC; Skipworth RJ
Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
[TBL] [Abstract][Full Text] [Related]
13. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
Graf SA; Garcia JM
Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacological management of anorexia in cancer patients.
Bruera E
Oncology (Williston Park); 1992 Jan; 6(1):125-30; discussion 132, 137. PubMed ID: 1531597
[TBL] [Abstract][Full Text] [Related]
15. Current and future care of patients with the cancer anorexia-cachexia syndrome.
Del Fabbro E
Am Soc Clin Oncol Educ Book; 2015; ():e229-37. PubMed ID: 25993178
[TBL] [Abstract][Full Text] [Related]
16. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
[TBL] [Abstract][Full Text] [Related]
17. Novel treatments for cancer cachexia.
Bossola M; Pacelli F; Doglietto GB
Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
[TBL] [Abstract][Full Text] [Related]
18. What is next after anamorelin?
Garcia JM
Curr Opin Support Palliat Care; 2017 Dec; 11(4):266-271. PubMed ID: 28957883
[TBL] [Abstract][Full Text] [Related]
19. North Central Cancer Treatment Group (NCCTG).
Loprinzi CL
J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472
[No Abstract] [Full Text] [Related]
20. Management of anorexia-cachexia associated with cancer and HIV infection.
Gorter R
Oncology (Williston Park); 1991 Sep; 5(9 Suppl):13-7. PubMed ID: 1721521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
